关注
Edward Weaver
Edward Weaver
在 qub.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Manufacturing of 3D-printed microfluidic devices for the synthesis of drug-loaded liposomal formulations
G Ballacchino, E Weaver, E Mathew, R Dorati, I Genta, B Conti, ...
International Journal of Molecular Sciences 22 (15), 8064, 2021
532021
The sustainability of emerging technologies for use in pharmaceutical manufacturing
E Weaver, C O’Hagan, DA Lamprou
Expert Opinion on Drug Delivery 19 (7), 861-872, 2022
392022
Microfluidics technology for the design and formulation of nanomedicines
E Jaradat, E Weaver, A Meziane, DA Lamprou
Nanomaterials 11 (12), 3440, 2021
332021
Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy
E Jaradat, E Weaver, A Meziane, DA Lamprou
International Journal of Pharmaceutics 628, 122320, 2022
262022
Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension
S Dhoble, V Patravale, E Weaver, DA Lamprou, T Patravale
International Journal of Pharmaceutics 621, 121792, 2022
232022
Microfluidic-mediated self-assembly of phospholipids for the delivery of biologic molecules
E Weaver, E O'Connor, DK Cole, A Hooker, S Uddin, DA Lamprou
International journal of pharmaceutics 611, 121347, 2022
232022
The present and future role of microfluidics for protein and peptide-based therapeutics and diagnostics
E Weaver, S Uddin, DK Cole, A Hooker, DA Lamprou
Applied Sciences 11 (9), 4109, 2021
212021
In-House Innovative “Diamond Shaped” 3D Printed Microfluidic Devices for Lysozyme-Loaded Liposomes
F Sommonte, E Weaver, E Mathew, N Denora, DA Lamprou
Pharmaceutics 14 (11), 2484, 2022
162022
Machine learning in additive manufacturing & Microfluidics for smarter and safer drug delivery systems
A Dedeloudi, E Weaver, DA Lamprou
International Journal of Pharmaceutics 636, 122818, 2023
152023
Development of Geraniol-Loaded Liposomal Nanoformulations against Salmonella Colonization in the Pig Gut
SI Ekonomou, P Akshay Thanekar, DA Lamprou, E Weaver, O Doran, ...
Journal of Agricultural and Food Chemistry 70 (23), 7004-7014, 2022
102022
Combining microfluidics and coaxial 3D-bioprinting for the manufacturing of diabetic wound healing dressings
C Fratini, E Weaver, S Moroni, R Irwin, YHD Bashi, S Uddin, L Casettari, ...
Biomaterials Advances 153, 213557, 2023
72023
The manufacturing and characterisation of eugenol-enclosed liposomes produced by microfluidic method
J Ghodke, SI Ekonomou, E Weaver, D Lamprou, O Doran, AC Stratakos
Foods 12 (15), 2940, 2023
72023
The manufacturing of 3D-printed microfluidic chips to analyse the effect upon particle size during the synthesis of lipid nanoparticles
E Weaver, E Mathew, J Caldwell, A Hooker, S Uddin, DA Lamprou
Journal of Pharmacy and Pharmacology 75 (2), 245-252, 2023
72023
Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method
E Jaradat, E Weaver, A Meziane, DA Lamprou
Molecular Pharmaceutics 20 (12), 6184-6196, 2023
42023
Emerging technologies for combating pandemics
E Weaver, S Uddin, DA Lamprou
Expert Review of Medical Devices 19 (7), 533-538, 2022
32022
Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles
E Weaver, F Sommonte, A Hooker, N Denora, S Uddin, DA Lamprou
Drug Delivery and Translational Research 14 (1), 266-279, 2024
22024
In-House Innovative “Diamond Shaped” 3D Printed Microfluidic Devices for Lysozyme-Loaded Liposomes. Pharmaceutics 2022, 14, 2484
F Sommonte, E Weaver, E Mathew, N Denora, DA Lamprou
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
22022
Liposomal encapsulation of amoxicillin via microfluidics with subsequent investigation of the significance of PEGylated therapeutics
E Weaver, RA Macartney, R Irwin, S Uddin, A Hooker, GA Burke, ...
International Journal of Pharmaceutics 650, 123710, 2024
12024
The Manufacturing and Characterisation of Eugenol-Enclosed Liposomes Produced by Microfluidic Method. Foods 2023, 12, 2940
J Ghodke, SI Ekonomou, E Weaver, D Lamprou, O Doran, AC Stratakos
12023
Microfluidics Technology for the Design and Formulation of Nanomedicines. Nanomaterials 2021, 11, 3440
E Jaradat, E Weaver, A Meziane, DA Lamprou
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
12021
系统目前无法执行此操作,请稍后再试。
文章 1–20